Toggle light / dark theme

What is the best approach for resuscitation of a patient with septic shock? Despite considerable investigation over several decades, this important question still has no clear answer. There is agreement that resuscitation should proceed quickly, for the longer the delay, the greater the physiologic stress and end-organ injury. However, treatment options are principally intravenous fluids and vasoactive agents, which have the capacity to both help or harm the patient. Thus, these therapies must be titrated in response to markers of the adequacy of resuscitation. The 2016 Surviving Sepsis Guidelines advocate that the principal marker of the adequacy of resuscitation is serum lactate. Serum lactate level is elevated when the body relies on anaerobic metabolism. As such, an elevated serum lactate level is a reflection of tissue hypoperfusion and thus considered axiomatic of shock. However, serum lactate level can be elevated in conditions other than shock and yet may not always be elevated in some shock states. Furthermore, lactate clearance is often considered too slow to provide timely feedback to clinicians regarding the consequences of their treatment decisions. Moreover, not all patients with shock can be cared for in settings with access to rapid-turnaround serum lactate assays.

An alternative approach is to monitor compensatory physiological mechanisms. For example, in response to shock, the body will attempt to restrict blood flow to peripheral vascular beds. Thus, one of the simplest bedside clinical examination findings in shock is delayed capillary refill in the skin. The problem with delayed capillary refill, however, is that the examination can be difficult to standardize. Furthermore, there has been little empirical evaluation of resuscitation strategies based on this finding.

In this issue of JAMA, Hernández and colleagues report the results of a clinical trial in which 424 adults with early septic shock were randomized to 2 alternative 8-hour resuscitation strategies: one based on serial measurements of serum lactate levels and the other on peripheral perfusion, assessed by serial capillary refill time (CRT) examinations. The trial was conducted among patients in the intensive care unit with early septic shock, defined as patients with suspected or confirmed infection who were recognized within 4 hours to have elevated serum lactate level (2 mmol/L) and require vasopressors to maintain blood pressure despite a bolus of 20 mL/kg of intravenous crystalloids.

Read more

Elon Musk believes there is a path for the SpaceX Super Heavy Starship (SHS) to be built for less than a Falcon 9. Currently, a single use SpaceX Falcon 9 can be purchased for about $62 million. The estimates for the cost of the SpaceX Super Heavy Starship (SHS) are about $250 to 400 million.

The current design of the SpaceX SHS has 38 Raptor engines. There are 31 Raptor engines in the Super Heavy booster and seven in the Starship upper stage. There are 9 Merlin engines in the SpaceX Falcon 9.

This will sound implausible, but I think there’s a path to build Starship / Super Heavy for less than Falcon 9

Read more

The stars aligned for a London based amateur astronomer, who managed to catch a shot of the International Space Station passing in front of the moon under the perfect conditions, with epic results.

Spotting ISS’s lunar crossings is extremely rare, making the close-up footage of the vessel’s swift passage particularly remarkable. While other amateurs have captured similar crossings, Szabolcs Nagy’s clip is incredibly close and clear, showing the manned satellite streaking through the center of the frame.

The Elon Musk funded OpenAI non-profit has created a breakthrough system for writing high-quality text. It can write text, performs basic reading comprehension, machine translation, question answering, and summarization and all without task-specific training.

The system is able to take a few sentences of sample writing and then produce a multi-paragraph article in the style and context of the sample. This capability would let AI’s to impersonate the writing style of any person from previous writing samples.

GPT-2, is a 1.5 billion parameter Transformer that achieves state of the art results on 7 out of 8 tested language modeling datasets in a zero-shot setting, yet still simplifies (or in AI term underfits) their database called WebText. Samples from the model reflect these improvements and contain coherent paragraphs of text. These findings suggest a promising path towards building language processing systems which learn to perform tasks from their naturally occurring demonstrations.

Read more

Valneva SE announced final Phase 1 study data and positive initial booster data for its Lyme Disease vaccine candidate VLA15.

“The positive final Phase 1 data for VLA15 supports and validates our plans to continue developing a safe and effective preventative vaccine that can be delivered to those who are at risk of Lyme disease infection,” said Thomas Lingelbach, CEO of Valneva.

“We look forward to continuing the development process with our recently initiated Phase 2 study. We continue to fully commit ourselves to addressing the significant unmet need for a vaccine against Lyme disease.”

Read more